MPZP: A novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist

This publication has 82 references indexed in Scilit:

• Effects of naltrexone, duloxetine, and a corticotropin-releasing factor type 1 receptor antagonist on binge-like alcohol drinking in rats
  Behavioural Pharmacology, 2008
• Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout
  Pharmacology Biochemistry and Behavior, 2007
• Corticotropin-Releasing Factor 1 Antagonists Selectively Reduce Ethanol Self-Administration in Ethanol-Dependent Rats
  Biological Psychiatry, 2007
• Variation at the ratCrhr1locus and sensitivity to relapse into alcohol seeking induced by environmental stress
  Proceedings of the National Academy of Sciences, 2006
• Ligand Affinity for Amino-Terminal and Juxtamembrane Domains of the Corticotropin Releasing Factor Type I Receptor: Regulation by G-Protein and Nonpeptide Antagonists
  Biochemistry, 2004
• Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain
  Neuron, 1993
• The effect of corticotropin-releasing factor (CRF) on autonomic and behavioral responses during shock-prod burying test in rats
  Peptides, 1992
• Activating and ‘anxiogenic’ effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone
  Life Sciences, 1986
• Organization of Ovine Corticotropin-Releasing Factor Immunoreactive Cells and Fibers in the Rat Brain: An Immunohistochemical Study
  Neuroendocrinology, 1983
• Conditioned defensive burying: A new paradigm for the study of anxiolytic agents
  Pharmacology Biochemistry and Behavior, 1981